Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

FDA issues recall on infusion pump parts due to risk of uncontrollable drug flow

Due to a risk of fatal overdose, the recall is labeled as the most serious of its type. While no patients have died, two have reportedly been injured. 

FDA recalls Medtronic video laryngoscopes due to risk of explosion

One person has been reportedly injured and the recall has been labelled "most serious" by the FDA. 

Thumbnail

Baxter sells kidney care division to private equity firm for $3.8B

Carlyle Group will be the new owner of Vantive, once the sale finalizes in early 2025.

FDA recall on ventilators ranked ‘most serious’ after patient injury

Baxter is recalling its Life2000 Ventilator system due to a faulty battery charging dongle that could cause the systems to shut off during use.

the words "FDA recall" on a board

FDA and Medtronic issue recall on endotracheal tubes due to risk of death

All Medtronic EMG Reinforced Endotracheal Tubes are being recalled due to a risk of collapse that could lead to serious injury or death.

cancer disparities health equity

In a national survey, 89% of cancer centers report drug shortages

Respondents said supply chain issues are running afoul of prior authorization requirements, leading to delays in patient care. 

CVS Health announces $10.6B acquisition of Oak Street Health

CVS generic drugs twice as likely to be recalled over safety concerns, investigation finds

CVS generics have been linked to more than 15 manufacturers cited for producing allegedly contaminated drugs.

FDA announces recall of Medline endotracheal tubes after three injuries

The Medline Sub-G endotracheal tubes with subglottic suction are defective and known to tear, potentially leading to serious injury or death.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?